Gilead Q4 Earnings and Income by Investing.com

Investing.com – Gilead (NASDAQ 🙂 reported on Thursday the fourth quarter that it beat analyst forecasts and revenue was above expectations. Gilead announced earnings per share of $ 2.19 on revenue of $ 7.33B. Analysts surveyed by Investing.com anticipated EPS of $ 2.01 on revenue of $ 7.03B. Gilead shares are up 13% since the beginning of the year, still 23.32% from their 52-week high of $ 85.90 set on March 19, 2020. They are outperforming Nasdaq, which is up 6, 9% from the beginning of the year. Gilead shares gained 1.72% in after-hours trading after the report. Gilead Follows Other Major Healthcare Gains This Month Gilead’s report follows an earnings hit from J&J on January 26, which reported EPS of $ 1.86 on revenue of $ 22.48B, compared to EPS forecasts of $ 1.82 on $ 21.66B revenue Roche Holding ADR had breached expectations on Monday with a fourth quarter EPS of $ 1.21 on $ 16.2B revenue, compared to the EPS forecast of $ 1.28 on $ 17.17B revenue. Stay up to date on all upcoming earnings reports by visiting the Investing.com earnings calendar.

Disclaimer: Fusion Media wishes to remind you that the data contained on this website is not necessarily accurate or in real time. All CFDs (stocks, indices, futures) and Forex prices are not provided by exchanges but by market makers, so prices may not be accurate and may differ from the actual market price, which means that prices are indicative and not appropriate for commercial purposes. Therefore, Fusion Media assumes no responsibility for any business losses you may incur as a result of the use of this data. data, quotes, charts and buy / sell signals contained in this website. Be fully informed about the risks and costs associated with trading financial markets, it is one of the riskiest investment forms possible.